ABSTRACT
Atherosclerosis is increased in type 2 diabetic patients but the precise mechanisms underlying this predisposition remain vague. Mice deficient for insulin receptor substrate 2 (IRS2) develop type 2-like diabetes and thus, provide a model to explore the molecular connection between deranged carbohydrate metabolism and atherosclerosis. To explore the relationship between defective insulin signalling and atherosclerosis, we have examined the development of atherosclerosis in the following groups of fat-fed mice: wild-type, diabetic Irs2-null (Irs2 
Irs2
-/-compared with apoE -/-mice, although both models displayed similar levels of severe hypercholesterolemia (>600 mg/dL). Circulating insulin levels predicted atherosclerotic lesion burden in apoE
-/-mice. Our results suggest that hyperinsulinemia as a result of Irs2 genetic ablation contributes to increased atherosclerosis when combined with severe hypercholesterolemia in the absence of hyperglycaemia (apoE
-/-mice), thus implicating IRS2 as an important modulator of murine hypercholesterolemia-dependent atherosclerosis. Future studies are necessary to determine whether IRS2 dysfunction may promote atherosclerosis in normoglycemic, pre-diabetic patients with clinical manifestations of hyperinsulinemia and insulin resistance.
INTRODUCTION
Diabetes mellitus affects approximately 100 million persons worldwide, with 90-95% of these patients suffering from type 2 diabetes (1). Diabetic patients have a 2 to 10-fold higher risk of atherosclerosis and cardiovascular disease than the general population (1,2). Type 2 diabetes and the metabolic syndrome are characterized by hyperglycemia, hyperinsulinemia, insulin resistance, obesity, hypertension and dyslipidemia. These factors produce vascular disorders which facilitate atherosclerotic lesion formation and plaque instability, and additionally, favor formation and persistence of thrombi (1, (3) (4) (5) . Both type 2 diabetes and metabolic syndrome are predicted to increase at alarming rates during the next 50 years due to the prevalence of unhealthy lifestyle habits (e. g., obesity and lack of physical exercise). Therefore, it is of utmost importance to develop relevant animal models to be used in unravelling the mechanisms which accelerate atherosclerosis in pre-diabetic individuals (eg., hyperinsulinemic, glucose intolerant) and diabetic patients.
Disruption of the Irs2 gene in the mouse produces pathological alterations very similar to type 2 diabetes and metabolic syndrome, including insulin resistance, hyperinsulinemia, glucose intolerance, obesity, hypertension, and moderate hyperlipidemia (6) (7) (8) (9) . Analysis of Irs2 -/-mice has revealed that IRS2 signals are required for proper development and function of pancreatic β-cells as well as for the central regulation of appetite (10, 11) . Indeed, beta cell-specific overexpression of IRS2 promotes beta cell growth, survival, and insulin secretion that prevents diabetes in Irs2 -/-, obese and streptozotocin-treated mice (12 
Irs2
-/-mice. Genotyping for Irs2 and apoE was done by PCR analysis as previously described (6) and as indicated by The Jackson Laboratory (http://jaxmice.org), respectively. After weaning, mice were maintained on a low-fat standard diet (2.8% fat; Panlab, Barcelona, Spain). At 2 months of age, mice received for 4 weeks an atherogenic diet containing 10.8% total fat, 0.75% cholesterol (S4892-E010, Ssniff, Soest, Germany).
Metabolic measurements
All measurements were performed with plasma of mice that were fasted overnight. Cholesterol, triglyceride and glucose levels were measured using enzymatic procedures (WAKO, St. Louis, USA). HDL-C and non-HDL-C were quantified after precipitation with Dextran-sulphate MgCl 2 (SIGMA, St. Louis, USA) as described (14). Insulin levels were quantified by ELISA (Mercodia, Sweeden). For glucose tolerance test, mice were injected with glucose (intraperitoneally, 2g/Kg of body weight) and plasma glucose levels were measured during 2 hours.
Atherosclerosis quantification
Fat-fed mice were killed, and after perfusion in situ with PBS followed by 4% paraformaldehyde/PBS, the heart and aorta were removed and fixation continued for 24h. A researcher blinded to genotype quantified the extent of atherosclerosis by computer-assisted morphometric analysis of whole-mounted aortic arch and thoracic aorta stained with Oil Red O (0.2% Oil Red O in 80% MeOH), and of aortic root cross-sections (intima-to-media ratio) as previously described (15) . Differences in lesion area between males and females were not significant, therefore data from both sexes are shown.
Immunohistochemical staining
Vascular smooth muscle cells (VSMCs) were identified with monoclonal alkaline phosphataseconjugated anti-smooth muscle alpha-actin (SM alphaactin) antibody (clone 1A4, 1/20 dilution, a-5691, SIGMA) using Fast Red substrate (SIGMA). Macrophages were identified with a rat monoclonal anti-Mac 3 IgG1 antibody (clone M3/84, 1/200 dilution, sc-19991; Santa Cruz Biotechnology, California, USA), using a biotinconjugated goat anti-rat IgG-B secondary antibody (sc-2041, Santa Cruz Biotechnology) and the ABC kit (VECTOR, Burlingame, USA) using DAB substrate (SEROTEC, Oxford, UK). Slides were counterstained with hematoxylin.
Statistics
Data are presented as mean±SE. Differences among groups were evaluated by 1-way ANOVA with Fisher's post-hoc test (Statview, SAS institute, Cary, USA). The F-test was used to measure the quality (significance) of regression analysis. Statistical significance was taken at p≤0.05.
RESULTS

Analysis of plasma glucose, insulin and lipid levels
To investigate the influence of deranged carbohydrate metabolism on diet-induced atherosclerosis, we examined the following groups of mice challenged for 4 weeks with an atherogenic diet enriched with fat and cholesterol: wild-type (WT), Irs2 
Irs2
-/-animals also died during the same phase of our study. Glucose levels in fat-fed WT, , but significantly higher than in WT and apoE-/-mice ( Figure  1B ). Fat-fed animals from all groups exhibited glucose intolerance, which was more severe in Irs2 -/-mice (data not shown). Body weight in apoE -/-and Irs2 -/-mice was comparable and higher than that of apoE
-/-mice ( Figure 1C Figure 2B ).
Accelerated atherosclerosis in fat-fed apoE -/-
Irs2
-/-mice can be predicted by high level of circulating insulin
We next examined in the four groups of mice fed the high-fat diet for 4 weeks the development of atherosclerosis in en face aortic preparations stained with Oil Red O ( Figure 3A) . Upon gross macroscopic examination, atherosclerotic lesions were largely absent within the aortic arch and thoracic aorta of WT and Irs2 -/-mice. In contrast, apoE -/-mice exhibited clearly visible atheromas, particularly within the aortic arch region, consistent with numerous studies in this mouse model. These observations were corroborated by computer- 
-/-versus apoE -/-mice (p<0.01), a tendency that was also noted within the thoracic aorta. Furthermore, quantification of the intima-to-media ratio (I/M) in transverse sections through the aortic sinus, a highly atherogenic vascular bed in the mouse, also demonstrated accelerated atherosclerosis in apoE
-/-mice (p=0.050 versus apoE -/-) ( Figure 4A ).
We carried out regression analysis to ascertain whether aortic arch atherosclerosis development correlated with metabolic parameters. As revealed by the F-test, atheroma size and circulating levels of glucose and cholesterol did not correlate in fat-fed apoE -/-and apoE
-/-mice (data not shown). However, this test revealed a significant direct correlation between plasma insulin level and aortic arch atherosclerotic lesion size in apoE
but not in apoE -/-mice ( Figure 5 ).
Neointimal VSMC and macrophage content is not altered in apoE -/-
Irs2
-/-versus apoE -/-mice We next carried out immunohistochemical studies in aortic sinus cross-sections to identify neointimal macrophages and VSMCs, using antibodies against Mac3 ( Figure 4B ) and SM alpha-actin ( Figure 4C) 
-/-mice did not reach statistical significance, the very small lesions in Irs2 -/-mice had a tendency towards reduced macrophage content, possibly due to the presence of undifferentiated monocytes which do not exhibit Mac3 immunoreactivity.
DISCUSSION
In this study using genetically-modified mice, we provide evidence that severe hypercholesterolemia imposed on IRS2 deficiency (>600 mg/dL, fat-fed apoE -/-
Irs2
-/-mouse) aggravates atherosclerosis. These findings are consistent with recently published studies demonstrating that partial (16) or global (17) Irs2 inactivation accelerate atheroma development in apoE -/-mice, and also contribute the following novel insight into the mechanisms that link IRS2 deficiency to atherosclerosis: 1) we found that atherosclerotic lesions were largely absent in fat-fed hyperinsulinemic, hyperglycaemic Irs2 -/-mice which presented more modest levels of plasma cholesterol (~280 mg/dL). Thus, in the absence of severe hypercholesterolemia, Irs2 disruption is not sufficient to promote atherosclerosis in the mouse. This is in marked contrast with the observation that normocholesterolemic (~70 mg/dL) Irs2 -/-mice display accelerated neointimal lesion development upon mechanical injury of the femoral artery (18); 2) our regression analysis indicates that atherosclerosis predisposition in apoE -/-
-/-mice can be predicted by circulating insulin levels; 3) in contrast, plasma glucose levels did not predict the burden of atherosclerosis in apoE -/-
-/-mice, and atheromas were largely absent in fat-fed hyperglycaemic Irs2 -/-mice. These findings highlight an important difference between type 1 and type 2 diabetes, since sustained hyperglycaemia alone without secondary lipid abnormalities is sufficient to accelerate murine atherosclerosis in the setting of type 1 diabetes (19, 20) . Further evidence that hyperglycaemia is not a predisposing factors for type 2 diabetes-induced atherosclerosis is provided by observations in various obesity-related models of diabetes and atherosclerosis (21-24); 4) we found that acceleration of atherosclerosis in apoE
-/-mice is not accompanied by changes in neointimal VSMC and macrophage content in early fatty streaks. Due to the high mortality rate associated with development of diabetes under conditions of IRS2 deficiency, it was impossible to evaluate whether this genetic manipulation may affect lesion composition at advanced disease states (eg., old fatfed apoE
-/-versus apoE -/-mice), and to investigate the effects on atherosclerosis of long-term exposure of Irs2 -/-mice to high-fat diet.
Surprisingly, we observed that fasting hyperglycaemia and glucose intolerance was ameliorated in apoE -/-
-/-in comparison with Irs2 -/-mice, which did not appear to be related to a preservation of beta-cell mass (data not shown). Previous studies have shown that Irs2 disruption upregulates the expression of lipogenic enzymes in the liver (25) , which in turn enhances hepatic lipid uptake as well as lipogenesis. Given that apoE is the major 
-/-versus Irs2 -/-mice may reflect a compensatory increase in lipogenesis to maintain lipid homeostasis.
Studies in mice (26) and humans (27, 28) have linked insulin signalling alterations with increased lipid accumulation in macrophages and foam cell formation due to enhanced CD36 receptor expression. Consistent with this, transplant of insulin receptor (IR)-null bone marrow into irradiated low-density lipoprotein receptor-null mice (Ldlr -/-) increased lipid uptake through the upregulation of CD36 and SRA, thereby aggravating atherosclerosis (29) . In contrast, Baumgartl and co-workers reported that macrophage-specific deficiency of either IR or IRS2 ameliorates atherosclerosis development in apoE -/-mice (17) . Although the reasons for this apparent discrepancy are unclear, it appears that modulation of glucose and insulin signalling in macrophages plays a direct role in lipid deposition and foam cell formation in the vessel wall.
Despite the presence of insulin resistance and maintenance on a high-fat diet, apoE
-/-mice did not develop obesity during our study ( Figure 1C ). In contrast, mice homozygous for the diabetes (Lepr db/db ) and obesity (Lep ob/ob ) mutations display phenotypes of obesity-induced diabetes (30) . When either of these models is combined with deficiency for apoE, atherosclerosis is enhanced in double mutants fed normal rodent chow and this tendency is further aggravated by high-fat regimen (21, 23, 24 
-/-mice was not associated with either obesity or aggravated dyslipidemia. However, one common feature of all these models is hyperinsulinemia, suggesting that plasma insulin levels predict atherosclerotic lesion burden. However, it should be noted that insulin resistance and hyperinsulinemia do not enhance atherosclerosis in Ldlr -/-mice under conditions of very high hypercholesterolemia (up to 2000 mg/dL) (31) . Thus, these different murine models offer excellent tools for unraveling distinct molecular links between atherosclerosis development and various risk factors associated with diabetes and metabolic syndrome.
In conclusion, our findings suggest that hyperglycaemia and hyperinsulinemia are not sufficient to promote atherosclerosis under conditions of mild hypercholesterolemia (~280 mg/dL, fat-fed Irs2 -/-mice). However, when combined with severe hypercholesterolemia (>600 mg/dL, fat-fed apoE -/-
-/-mice), the systemic insulin resistance produced by the absence of IRS2 facilitates the development of atherosclerosis in a manner that can be predicted by circulating insulin levels. Future studies are warranted to determine whether IRS2 dysfunction contributes to human atherosclerosis in individuals with hyperinsulinemia but without overt hyperglycaemia, and in type 2 diabetic patients with or without metabolic syndrome.
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